
|Videos|November 8, 2021
Advantages of Aquablation for patients and urologists
Author(s)Urology Times staff
Advertisement
In this video, Naeem Bhojani, MD, FRCSC, and David-Dan Nguyen discuss the patient selection, learning curve and takeaways of the study, “WATER vs WATER II: Three Year Comparison of Aquablation Therapy for Benign Prostatic Hyperplasia,” presented at the 2021 American Urological Association Annual Meeting. Bhojani is a urologist at CHUM Research Centre and an associate professor in the departments of surgery and social and preventative medicine at the University of Montreal, and Nguyen is a medical student at McGill University, Montreal, Quebec, Canada.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Joshua Lang, MD, MS, on integrating molecular biomarkers into clinical practice
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












